Furthermore, some cases out of a cohort of pancreatic cancer patients reveal coexpression of PD-L1 and the cytoplasmic insulin receptor in the tumor tissue as shown by immunohistochemistry. This evidence concerns the gene INSR and pancreatic neoplasm.